This inventor holds 6 USPTO granted patents and 1 published patent application, plus 2 CIPO patents and 3 EPO patents. Top assignees: Ucb Pharma, S.a., Celltech Chiroscience Limited, Ucb Celltech. Active years: 2006-2011.
Location History:
- Slough, GB (2007)
- Hampton, GB (2006 - 2011)
- Middlesex, GB (2011)
Company Filing History:
4 out of 180 
1 out of 1 
1 out of 1 Years Active: 2006-2011
Title: The Innovations of Andrew Paul Chapman
Introduction
Andrew Paul Chapman is a notable inventor based in Hampton, GB. He has made significant contributions to the field of biotechnology, particularly in the development of antibody fragments. With a total of 6 patents to his name, Chapman has demonstrated a commitment to advancing medical science through innovative solutions.
Latest Patents
Chapman's latest patents include groundbreaking work on divalent antibody fragments. These fragments are characterized by interchain bridges that contain synthetic or naturally occurring polymers. The unique design of these bridges allows for improved binding and pharmacokinetic properties compared to traditional antibody fragments. Another significant patent involves antibody molecules specific to human tumor necrosis factor alpha. This invention includes DNA sequences encoding the chains of the antibody molecules, which have potential applications in treating diseases mediated by TNFα.
Career Highlights
Throughout his career, Andrew Paul Chapman has worked with prominent companies in the pharmaceutical industry, including UCB Pharma and Celltech Chiroscience Limited. His work has been instrumental in developing therapies that leverage the power of antibody technology.
Collaborations
Chapman has collaborated with esteemed colleagues such as David J. King and Derek Thomas Brown. These partnerships have contributed to the success of his innovative projects and have furthered advancements in the field.
Conclusion
Andrew Paul Chapman is a distinguished inventor whose work in antibody technology has the potential to transform therapeutic approaches in medicine. His contributions continue to inspire future innovations in biotechnology.